LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

Pfizer

Fermé

SecteurSoins de santé

25.07 -2.79

Résumé

Variation du prix de l'action

24h

Actuel

Min

25.06

Max

25.23

Chiffres clés

By Trading Economics

Revenu

623M

3.6B

Ventes

2B

17B

P/E

Moyenne du Secteur

14.18

105.69

BPA

0.87

Rendement du dividende

6.96

Marge bénéficiaire

21.322

Employés

81,000

EBITDA

325M

5.6B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+16.04% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

6.96%

2.37%

Date du Prochain Dividende

1 déc. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.5B

139B

Ouverture précédente

27.86

Clôture précédente

25.07

Sentiment de l'Actualité

By Acuity

52%

48%

281 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Pfizer Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

13 nov. 2025, 17:39 UTC

Acquisitions, Fusions, Rachats

Pfizer Completes Acquisition of Metsera

10 nov. 2025, 13:08 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

10 nov. 2025, 09:41 UTC

Acquisitions, Fusions, Rachats

Novo Nordisk Shares Rise After Withdrawal of Metsera Takeover Battle

14 nov. 2025, 12:22 UTC

Market Talk
Acquisitions, Fusions, Rachats

Pharma Sector Becoming Bidding Battlefield -- Market Talk

13 nov. 2025, 16:26 UTC

Acquisitions, Fusions, Rachats

Pfizer Completes Acquisition Of Metsera >PFE

10 nov. 2025, 16:35 UTC

Market Talk
Acquisitions, Fusions, Rachats

Pfizer CEO Confident Metsera Therapies Will Get Approval -- Market Talk

10 nov. 2025, 16:26 UTC

Market Talk
Acquisitions, Fusions, Rachats

Pfizer CEO: Metsera Has Exciting Weight-Loss Portfolio -- Market Talk

10 nov. 2025, 15:36 UTC

Acquisitions, Fusions, Rachats

What's Next for Novo Nordisk? -- WSJ

10 nov. 2025, 14:05 UTC

Market Talk
Acquisitions, Fusions, Rachats

Pfizer Will See Big Benefits from Metsera Acquisition -- Market Talk

10 nov. 2025, 12:33 UTC

Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 nov. 2025, 12:32 UTC

Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, Monday.com, CoreWeave, and More -- Barrons.com

10 nov. 2025, 10:45 UTC

Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, Rumble, CoreWeave, and More -- Barrons.com

10 nov. 2025, 10:34 UTC

Acquisitions, Fusions, Rachats

These Stocks Are Moving the Most Today: Metsera, Pfizer, Nvidia, Tesla, CoreWeave, and More -- Barrons.com

10 nov. 2025, 10:32 UTC

Actions en Tendance

Stocks to Watch Monday: Metsera, Novo Nordisk, Nvidia, Tyson Foods -- WSJ

10 nov. 2025, 09:26 UTC

Acquisitions, Fusions, Rachats

Novo Nordisk Shares Rise After Withdrawal From Metsera Takeover Battle

8 nov. 2025, 13:10 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 nov. 2025, 03:50 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 nov. 2025, 03:41 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 nov. 2025, 03:07 UTC

Acquisitions, Fusions, Rachats

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 nov. 2025, 13:26 UTC

Acquisitions, Fusions, Rachats

Correction to This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. Article -- WSJ

7 nov. 2025, 10:30 UTC

Acquisitions, Fusions, Rachats

This Unlikely Duo Is Developing a Weight-Loss Pill. Big Pharma Is Obsessed. -- WSJ

6 nov. 2025, 20:02 UTC

Acquisitions, Fusions, Rachats

Biotech M&A Deals Are Trickier Than They Look. Watch the Milestone Payments. -- Barrons.com

6 nov. 2025, 16:16 UTC

Résultats

Moderna's Quarter Wasn't As Bad as It Could Have Been. The Stock is Up -- Barrons.com

6 nov. 2025, 12:29 UTC

Résultats

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 nov. 2025, 12:15 UTC

Résultats

Moderna Swings to a Loss. The Stock Jumps Anyway. -- Barrons.com

6 nov. 2025, 00:24 UTC

Acquisitions, Fusions, Rachats

Metsera: Pfizer Has Reiterated It Will Continue to Litigate >MTSR

6 nov. 2025, 00:24 UTC

Acquisitions, Fusions, Rachats

Metsera: Board of Directors Will Continue to Stand Firm on Behalf of Shareholders, Patients >MTSR

6 nov. 2025, 00:24 UTC

Acquisitions, Fusions, Rachats

Metsera: Gratified by Court Decision to Deny Pfizer's Request for Temporary Restraining Order to Block Board From Acting in Shareholders' Best Interests >MTSR

6 nov. 2025, 00:22 UTC

Acquisitions, Fusions, Rachats

Metsera Issues Statement in Response to Pfizer Litigation Ruling

5 nov. 2025, 22:44 UTC

Acquisitions, Fusions, Rachats

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

Comparaison

Variation de prix

Pfizer prévision

Objectif de Prix

By TipRanks

16.04% hausse

Prévisions sur 12 Mois

Moyen 29.08 USD  16.04%

Haut 34 USD

Bas 24 USD

Basé sur 15 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

15 ratings

4

Achat

10

Maintien

1

Vente

Score Technique

By Trading Central

22.855 / 23.85Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

281 / 374Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat